Milestone Scientific Commences Declaratory Judgment Action With Respect to Its Single Tooth Anesthesia (STA(TM)) System and Comp
September 12 2007 - 8:30AM
PR Newswire (US)
Defendant Brings Infringement Action LIVINGSTON, N.J., Sept. 12
/PRNewswire-FirstCall/ -- Milestone Scientific, Inc. (OTC:MLSS)
(BULLETIN BOARD: MLSS) today announced that on August 24, 2007 it
commenced a Declaratory Judgment Action against Milton Hodosh, DMD
in the United States District Court for the District of New Jersey
seeking a determination by that Court that neither its Single Tooth
Anesthesia (STA(TM)) system nor its CompuDent(TM) system infringed
claims set forth in United States Patent No. 6159161 filed by Dr.
Hodosh on July 8, 1998 and issued by the United States Patent
Office on December 12, 2000. Milestone's basic patents covering
these systems were issued by the United States Patent Office in
January 1993. Subsequent to the commencement of Milestone's action
for a Declaratory Judgment, Dr. Hodosh commenced a patent
infringement suit in the United States District Court for the
Southern District of New York. Milestone has received opinions from
patent counsel, not involved in the litigations, to the effect that
neither the STA(TM) system nor the Compudent(TM) system infringe
any of the claims of Dr. Hodosh's patents. Milestone believes that
it has meritorious defenses to Dr. Hodosh's action and it intends
to vigorously defend this law suit. Issue has not yet been joined
in either action and Milestone's counsel is considering whether or
not it will seek to consolidate these actions which, essentially,
deal with the same subject matter. About Milestone Scientific, Inc.
Headquartered in Livingston, New Jersey, Milestone Scientific is
engaged in pioneering proprietary, highly innovative technological
solutions for the medical and dental markets. Central to the
Company's IP platform and product development strategy is its
patented CompuFlo(TM) technology for the improved delivery of local
anesthetic below a patient's threshold of pain. Specifically,
CompuFlo is a computer-controlled, pressure sensitive infusion,
perfusion, suffusion and aspiration technology, which provides
real-time readouts of pressures, fluid densities and flow rates,
enabling the advanced delivery and removal of a wide array of
fluids. The STA(TM) System, a computer-controlled local anesthesia
delivery (CCLAD) system which uses this technology provides
dentists with audible and visual signals as to in-tissue pressure.
Milestone's existing injection systems are currently sold in 25
countries. For more information on these and other innovative
Milestone products, please visit the Company's web site found at
http://www.milesci.com/. Safe Harbor Statement This press release
contains forward-looking statements regarding the timing and
financial impact of the Milestone's ability to implement its
business plan, expected revenues and future success. These
statements involve a number of risks and uncertainties and are
based on assumptions involving judgments with respect to future
economic, competitive and market conditions and future business
decisions, all of which are difficult or impossible to predict
accurately and many of which are beyond Milestone's control. Some
of the important factors that could cause actual results to differ
materially from those indicated by the forward-looking statements
are general economic conditions, failure to achieve expected
revenue growth, changes in our operating expenses, adverse patent
rulings, FDA or legal developments, competitive pressures, changes
in customer and market requirements and standards, and the risk
factors detailed from time to time in Milestone's periodic filings
with the Securities and Exchange Commission, including without
limitation, Milestone's Annual Report on Form 10-KSB for the year
ended December 31, 2006. The forward looking-statements in this
press release are based upon management's reasonable belief as of
the date hereof. Milestone undertakes no obligation to revise or
update publicly any forward-looking statements for any reason. FOR
MORE INFORMATION, PLEASE CONTACT: Elite Financial Communications
Group, LLC Dodi Handy, President and CEO, or Daniel Conway, Chief
Strategist 407-585-1080 or via email at DATASOURCE: Milestone
Scientific, Inc. CONTACT: Dodi Handy, President and CEO, or Daniel
Conway, Chief Strategist, both of Elite Financial Communications
Group, LLC, +1-407-585-1080, , for Milestone Scientific, Inc. Web
site: http://www.milesci.com/
Copyright